We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
-5.98%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.92B
AUM Growth
-$382M
Cap. Flow
-$115M
Cap. Flow %
-5.98%
Top 10 Hldgs %
45.28%
Holding
275
New
41
Increased
31
Reduced
101
Closed
38

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$24.8M
2
ASTH icon
Astrana Health
ASTH
+$16.6M
3
KSPI icon
Kaspi.kz JSC
KSPI
+$15.8M
4
LLY icon
Eli Lilly
LLY
+$15.2M
5
GPC icon
Genuine Parts
GPC
+$13M

Top Sells

Rank Stock Value
1
UWMC icon
UWM Holdings
UWMC
+$30.9M
2
WDC icon
Western Digital
WDC
+$24.7M
3
HRMY icon
Harmony Biosciences
HRMY
+$13.6M
4
SUNC
SunocoCorp LLC
SUNC
+$11.6M
5
GXO icon
GXO Logistics
GXO
+$10.6M

Sector Composition

Rank Sector Weight
1 Healthcare 23.91%
2 Consumer Discretionary 7.8%
3 Financials 6.79%
4 Industrials 3.72%
5 Materials 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FOSL icon
151
Fossil Group
FOSL
$239M
$754K 0.04%
175,000
-83,065
-32% -$335K
AMTX icon
152
Aemetis
AMTX
$119M
$751K 0.04%
235,557
– –
KYTX icon
153
Kyverna Therapeutics
KYTX
$450M
$734K 0.04%
85,000
-29,900
-26% -$249K
DUOT icon
154
Duos Technologies
DUOT
$254M
$730K 0.04%
106,481
– –
CTNM
155
Contineum Therapeutics
CTNM
$526M
$718K 0.04%
55,000
-36,442
-40% -$489K
UMAC icon
156
Unusual Machines
UMAC
$925M
$682K 0.04%
55,000
-29,751
-35% -$453K
SPCE icon
157
Virgin Galactic
SPCE
$320M
$681K 0.04%
280,160
– –
LODE icon
158
Comstock
LODE
$228M
$671K 0.04%
220,000
-56,243
-20% -$184K
SGMT icon
159
Sagimet Biosciences
SGMT
$437M
$660K 0.03%
126,349
– –
MODD icon
160
Modular Medical
MODD
$13.6M
$660K 0.03%
125,001
+66,264
+113% +$710K
ZURA icon
161
Zura Bio
ZURA
$497M
$655K 0.03%
110,000
-149,165
-58% -$901K
LPTH icon
162
Lightpath Technologies
LPTH
$680M
$652K 0.03%
65,000
-68,595
-51% -$787K
CAE icon
163
CAE Inc. Common Shares
CAE
$8.1B
$651K 0.03%
25,000
– –
VTVT icon
164
vTv Therapeutics
VTVT
$121M
$635K 0.03%
16,000
-2,268
-12% -$82.3K
CLYM
165
Climb Bio
CLYM
$735M
$617K 0.03%
90,000
-111,652
-55% -$644K
MRAM icon
166
Everspin Technologies
MRAM
$354M
$615K 0.03%
70,000
-39,943
-36% -$440K
GSIT icon
167
GSI Technology
GSIT
$216M
$611K 0.03%
118,835
– –
CABA icon
168
Cabaletta Bio
CABA
$439M
$605K 0.03%
225,000
-163,562
-42% -$454K
ELTX icon
169
Elicio Therapeutics
ELTX
$78.8M
$603K 0.03%
56,442
– –
ACHV icon
170
Achieve Life Sciences
ACHV
$626M
$588K 0.03%
200,000
-14,897
-7% -$66.2K
CCLD icon
171
CareCloud
CCLD
$94.3M
$583K 0.03%
159,761
– –
LTRX icon
172
Lantronix
LTRX
$236M
$576K 0.03%
110,000
-96,398
-47% -$589K
FCEL icon
173
FuelCell Energy
FCEL
$1.7B
$556K 0.03%
85,110
-34,890
-29% -$269K
BDTX icon
174
Black Diamond Therapeutics
BDTX
$101M
$528K 0.03%
247,958
– –
HYMC icon
175
Hycroft Mining Holding Corp
HYMC
$1.85B
$528K 0.03%
15,000
-35,000
-70% -$1.35M
5 6
7
8 9

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

683 Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, 683 Capital Management held 275 positions worth $1.92B, down 17% from $2.3B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

683 Capital Management withdrew a net $115M in Q1 2026, closing 38 positions and reducing 101 holdings. Its most notable exit was UWM Holdings, an estimated $30.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, 683 Capital Management opened a new position in Astrana Health worth $17.2M.

  • 683 Capital Management's largest Q1 2026 buy was Astrana Health: 700,000 shares worth $17.2M.
  • 683 Capital Management added most to Becton Dickinson in Q1 2026, an estimated $24.8M increase.
  • 683 Capital Management's biggest Q1 2026 reduction was GXO Logistics, cutting an estimated $10.6M.
  • 683 Capital Management fully exited UWM Holdings in Q1 2026, selling an estimated $30.9M.
  • 683 Capital Management's ten largest holdings make up 45% of its $1.92B portfolio in Q1 2026.
  • 683 Capital Management opened 41 new positions and closed 38 in Q1 2026.
  • 683 Capital Management's portfolio value fell 17% quarter-over-quarter to $1.92B.

Based on 683 Capital Management's 13F filing for Q1 2026, filed 15 May 2026.